Educational content on VJDementia is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ARUK 2022 | Novel agents to treat psychosis in Alzheimer’s disease

Byron Creese, PhD, University of Exeter Medical School, Exeter, UK, discusses treatments for psychosis in Alzheimer’s disease that are currently being investigated. There is a great unmet need for novel treatments in this area. Pimavanserin shows promise but there is debate as to its efficacy. This interview took place at the Alzheimer’s Research UK Conference 2022 in Brighton, UK.